Impact of Prophylactic Corticosteroid Use on In-hospital Mortality and Respiratory Failure After Esophagectomy for Esophageal Cancer
暂无分享,去创建一个
H. Yasunaga | K. Fushimi | H. Daiko | O. Itano | Y. Kitagawa | H. Matsui | H. Kawakubo | H. Kaneko | S. Matsuda | K. Uda | H. Itoh | T. Konishi | Y. Hirano
[1] H. Yasunaga,et al. Validity of initial cancer diagnoses in the Diagnosis Procedure Combination data in Japan. , 2021, Cancer epidemiology.
[2] H. Shinozaki,et al. Pharmacological treatment to reduce pulmonary morbidity after esophagectomy , 2021, Annals of gastroenterological surgery.
[3] S. Jaber,et al. Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery: multicentre, double blind, randomised controlled trial , 2021, BMJ.
[4] A. Zarbock,et al. Systemic Inflammatory Response Syndrome After Surgery: Mechanisms and Protection , 2020, Anesthesia and analgesia.
[5] O. Dekkers,et al. The efficacy and safety of prophylactic corticosteroids for the prevention of adverse outcomes in patients undergoing heart surgery using cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials. , 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[6] Jessica M Franklin,et al. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners , 2019, BMJ.
[7] H. Shinozaki,et al. Administration of Corticosteroids, Ascorbic Acid, and Thiamine Improves Oxygenation after Thoracoscopic Esophagectomy , 2019, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[8] B. Beck-Schimmer,et al. Cytokine Response in the Pleural Fluid and Blood in Minimally Invasive and Open Esophagectomy , 2019, World Journal of Surgery.
[9] E. Goldmuntz,et al. 2-Year Outcomes After Complete or Staged Procedure for Tetralogy of Fallot in Neonates. , 2019, Journal of the American College of Cardiology.
[10] R. Engelman,et al. Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery Society Recommendations. , 2019, JAMA surgery.
[11] H. Yasunaga,et al. Comparing Perioperative Mortality and Morbidity of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer , 2019, Annals of surgery.
[12] O. Ljungqvist,et al. Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations , 2018, World Journal of Surgery.
[13] Masahiro Yoshida,et al. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2 , 2018, Esophagus.
[14] Kazuhiro Yoshida,et al. Immediate extubation after esophagectomy with three-field lymphadenectomy enables early ambulation in patients with thoracic esophageal cancer , 2018, Esophagus.
[15] A. Chang,et al. Benchmarking Complications Associated with Esophagectomy , 2017, Annals of surgery.
[16] G. Rücker,et al. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. , 2017, The Cochrane database of systematic reviews.
[17] K. Moorthy,et al. Component analysis of enhanced recovery pathways for esophagectomy. , 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[18] H. Horiguchi,et al. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data , 2017, Journal of epidemiology.
[19] François Alla,et al. The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality , 2016, Medical care.
[20] S. Yusuf,et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial , 2015, The Lancet.
[21] R. van Hillegersberg,et al. The effect of perioperative administration of glucocorticoids on pulmonary complications after transthoracic oesophagectomy: A systematic review and meta-analysis , 2014, European journal of anaesthesiology.
[22] Y. Doki,et al. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society , 2014, Esophagus.
[23] R. Marshall,et al. Enhanced Recovery for Esophagectomy: A Systematic Review and Evidence-Based Guidelines , 2014, Annals of surgery.
[24] Long-Qi Chen,et al. Effect of perioperative glucocorticoid administration on postoperative complications following esophagectomy: A meta-analysis , 2013, Oncology letters.
[25] A. Kosinski,et al. Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. , 2013, The Annals of thoracic surgery.
[26] J. Tijssen,et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. , 2012, JAMA.
[27] T. Yu,et al. Preoperative Glucocorticoid Use in Major Abdominal Surgery: Systematic Review and Meta-Analysis of Randomized Trials , 2011, Annals of surgery.
[28] Bing Li,et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. , 2011, American journal of epidemiology.
[29] E. Engelman,et al. Effect of Preoperative Single-Dose Corticosteroid Administration on Postoperative Morbidity Following Esophagectomy , 2010, Journal of Gastrointestinal Surgery.
[30] E. Oki,et al. Evaluation of the feasibility and safety of immediate extubation after esophagectomy with extended radical three-field lymph node dissection for thoracic esophageal cancers , 2009, Esophagus.
[31] M. Raebel,et al. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[32] Y. Nishimura,et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus , 2008, Esophagus.
[33] H. Kuwano,et al. Effect of perioperative steroid therapy on the postoperative course of patients with oesophageal cancer. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[34] H. Quan,et al. Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.
[35] C. Nishida,et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.
[36] J. Hanley,et al. Statistical analysis of correlated data using generalized estimating equations: an orientation. , 2003, American journal of epidemiology.
[37] T. Iwaya,et al. Randomized Study of the Benefits of Preoperative Corticosteroid Administration on the Postoperative Morbidity and Cytokine Response in Patients Undergoing Surgery for Esophageal Cancer , 2002, Annals of surgery.
[38] M. Arima,et al. Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. , 2000, Surgery.
[39] H. Yasunaga,et al. Introduction to Instrumental Variable Analysis , 2020, Annals of Clinical Epidemiology.
[40] H. Yasunaga. Introduction to Applied Statistics—Chapter 1 Propensity Score Analysis , 2020, Annals of Clinical Epidemiology.
[41] Hideo Yasunaga,et al. Real World Data in Japan: Chapter II The Diagnosis Procedure Combination Database , 2019, Annals of Clinical Epidemiology.